Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad I Husain

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Bjpsych Open|February 15, 2019
Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trialMuhammad I Husain, Imran B Chaudhry, Ameer B Khoso, et al.
Bipolar Disorders|September 10, 2021
Efficacy and acceptability of pharmacotherapy for comorbid anxiety symptoms in bipolar disorder: A systematic review and meta-analysisClare Cullen, Nils Kappelmann, Madeha Umer, et al.
Npj Mental Health Research|February 22, 2026
A systematic exploration of digital biomarkers for the detection of depressive episodes in bipolar disorderRamzi Halabi, Benoit H Mulsant, Mirkamal Tolend, et al.
CNS Spectrums|May 9, 2023
Associations between peripheral inflammation and clinical phenotypes of bipolar depression in a lower-middle income countryBrett D M Jones, Urbee Mahmood, John Hodsoll, et al.
Journal of Psychosomatic Research|April 2, 2019
Depression and congestive heart failure: A large prospective cohort study from PakistanMuhammad I Husain, Imran B Chaudhry, Muhammad O Husain, et al.
Bipolar Disorders|December 14, 2022
Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depressionFarhan Fancy, Nelson B Rodrigues, Joshua D Di Vincenzo, et al.
Focus (American Psychiatric Publishing)|May 2, 2024
Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar DepressionFarhan Fancy, Nelson B Rodrigues, Joshua D Di Vincenzo, et al.
Eclinicalmedicine|May 30, 2024
Dietary supplement for mood symptoms in early postpartum: a double-blind randomized placebo controlled trialJeffrey H Meyer, ZhaoHui Wang, Apitharani Santhirakumar, et al.
Trials|July 3, 2024
Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depressionJoshua M Poulin, Gregory E Bigford, Krista L Lanctôt, et al.
Pharmacopsychiatry|July 6, 2022
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) StudyHelena K Kim, Gwyneth Zai, Daniel J Müller, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Bjpsych Open|February 15, 2019
Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trialMuhammad I Husain, Imran B Chaudhry, Ameer B Khoso, et al.
Bipolar Disorders|September 10, 2021
Efficacy and acceptability of pharmacotherapy for comorbid anxiety symptoms in bipolar disorder: A systematic review and meta-analysisClare Cullen, Nils Kappelmann, Madeha Umer, et al.
Npj Mental Health Research|February 22, 2026
A systematic exploration of digital biomarkers for the detection of depressive episodes in bipolar disorderRamzi Halabi, Benoit H Mulsant, Mirkamal Tolend, et al.
CNS Spectrums|May 9, 2023
Associations between peripheral inflammation and clinical phenotypes of bipolar depression in a lower-middle income countryBrett D M Jones, Urbee Mahmood, John Hodsoll, et al.
Journal of Psychosomatic Research|April 2, 2019
Depression and congestive heart failure: A large prospective cohort study from PakistanMuhammad I Husain, Imran B Chaudhry, Muhammad O Husain, et al.
Bipolar Disorders|December 14, 2022
Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depressionFarhan Fancy, Nelson B Rodrigues, Joshua D Di Vincenzo, et al.
Focus (American Psychiatric Publishing)|May 2, 2024
Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar DepressionFarhan Fancy, Nelson B Rodrigues, Joshua D Di Vincenzo, et al.
Eclinicalmedicine|May 30, 2024
Dietary supplement for mood symptoms in early postpartum: a double-blind randomized placebo controlled trialJeffrey H Meyer, ZhaoHui Wang, Apitharani Santhirakumar, et al.
Trials|July 3, 2024
Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depressionJoshua M Poulin, Gregory E Bigford, Krista L Lanctôt, et al.
Pharmacopsychiatry|July 6, 2022
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) StudyHelena K Kim, Gwyneth Zai, Daniel J Müller, et al.
Pageof 4